These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38166448)

  • 1. Unlocking the Molecular Variations of a Micron-Scale Amyloid Plaque in an Early Stage Alzheimer's Disease by a Cellular-Resolution Mass Spectrometry Imaging Platform.
    Lv Y; Yan S; Deng K; Chen Z; Yang Z; Li F; Luo Q
    ACS Chem Neurosci; 2024 Jan; 15(2):337-345. PubMed ID: 38166448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
    Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
    J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Trimodal MALDI Imaging Mass Spectrometry (IMS3) at 10 μm Reveals Spatial Lipid and Peptide Correlates Implicated in Aβ Plaque Pathology in Alzheimer's Disease.
    Kaya I; Brinet D; Michno W; Başkurt M; Zetterberg H; Blenow K; Hanrieder J
    ACS Chem Neurosci; 2017 Dec; 8(12):2778-2790. PubMed ID: 28925253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shedding Light on the Molecular Pathology of Amyloid Plaques in Transgenic Alzheimer's Disease Mice Using Multimodal MALDI Imaging Mass Spectrometry.
    Kaya I; Zetterberg H; Blennow K; Hanrieder J
    ACS Chem Neurosci; 2018 Jul; 9(7):1802-1817. PubMed ID: 29648443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delineating Amyloid Plaque Associated Neuronal Sphingolipids in Transgenic Alzheimer's Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry.
    Kaya I; Brinet D; Michno W; Syvänen S; Sehlin D; Zetterberg H; Blennow K; Hanrieder J
    ACS Chem Neurosci; 2017 Feb; 8(2):347-355. PubMed ID: 27984697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain region-specific amyloid plaque-associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer's disease mice.
    Kaya I; Jennische E; Lange S; Tarik Baykal A; Malmberg P; Fletcher JS
    J Neurochem; 2020 Jul; 154(1):84-98. PubMed ID: 32141089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural amyloid plaque polymorphism is associated with distinct lipid accumulations revealed by trapped ion mobility mass spectrometry imaging.
    Michno W; Wehrli PM; Koutarapu S; Marsching C; Minta K; Ge J; Meyer SW; Zetterberg H; Blennow K; Henkel C; Oetjen J; Hopf C; Hanrieder J
    J Neurochem; 2022 Feb; 160(4):482-498. PubMed ID: 34882796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial Neurolipidomics at the Single Amyloid-β Plaque Level in Postmortem Human Alzheimer's Disease Brain.
    Michno W; Bowman A; Jha D; Minta K; Ge J; Koutarapu S; Zetterberg H; Blennow K; Lashley T; Heeren RMA; Hanrieder J
    ACS Chem Neurosci; 2024 Feb; 15(4):877-888. PubMed ID: 38299453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass Spectrometry Imaging in Alzheimer's Disease.
    Ikegawa M; Kakuda N; Miyasaka T; Toyama Y; Nirasawa T; Minta K; Hanrieder J
    Brain Connect; 2023 Aug; 13(6):319-333. PubMed ID: 36905365
    [No Abstract]   [Full Text] [Related]  

  • 10. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
    Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer's disease.
    Michno W; Wehrli P; Meier SR; Sehlin D; Syvänen S; Zetterberg H; Blennow K; Hanrieder J
    J Neurochem; 2020 Mar; 152(5):602-616. PubMed ID: 31605538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetramodal Chemical Imaging Delineates the Lipid-Amyloid Peptide Interplay at Single Plaques in Transgenic Alzheimer's Disease Models.
    Ge J; Koutarapu S; Jha D; Dulewicz M; Zetterberg H; Blennow K; Hanrieder J
    Anal Chem; 2023 Mar; 95(10):4692-4702. PubMed ID: 36856542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GM1 locates to mature amyloid structures implicating a prominent role for glycolipid-protein interactions in Alzheimer pathology.
    Michno W; Wehrli PM; Zetterberg H; Blennow K; Hanrieder J
    Biochim Biophys Acta Proteins Proteom; 2019 May; 1867(5):458-467. PubMed ID: 30273679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
    Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
    Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry.
    Ikegawa M; Nirasawa T; Kakuda N; Miyasaka T; Kuzuhara Y; Murayama S; Ihara Y
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30907869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal Chemical Imaging of Amyloid Plaque Polymorphism Reveals Aβ Aggregation Dependent Anionic Lipid Accumulations and Metabolism.
    Michno W; Kaya I; Nyström S; Guerard L; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    Anal Chem; 2018 Jul; 90(13):8130-8138. PubMed ID: 29856605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Lipid Dynamics in Amyloid Precursor Protein/Presenilin 1 Mouse Model of Early Alzheimer's Disease by Desorption Electrospray Ionization and Matrix Assisted Laser Desorption Ionization-Mass Spectrometry Imaging Techniques.
    Zhang X; Wu C; Tan W
    J Proteome Res; 2021 May; 20(5):2643-2650. PubMed ID: 33780243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.
    Poduslo JF; Curran GL; Peterson JA; McCormick DJ; Fauq AH; Khan MA; Wengenack TM
    Biochemistry; 2004 May; 43(20):6064-75. PubMed ID: 15147190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal Imaging of Amyloid Plaques: Fusion of the Single-Probe Mass Spectrometry Image and Fluorescence Microscopy Image.
    Tian X; Xie B; Zou Z; Jiao Y; Lin LE; Chen CL; Hsu CC; Peng J; Yang Z
    Anal Chem; 2019 Oct; 91(20):12882-12889. PubMed ID: 31536324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid imaging of Alzheimer's disease pathology.
    Hanrieder J
    J Neurochem; 2024 Jul; 168(7):1175-1178. PubMed ID: 38372595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.